GlycoMar Limited

Drug Discovery Screening Solutions

GlycoMar specialist screening facility has been established to provide flexible in vitro drug discovery screening services to a wide range of organisations involved in therapeutic discovery. The drug discovery services effectively reduce your costs and timelines and facilitate you in the process of meeting your drug discovery screening solutions milestones. The main factors driving the drug discovery services market is the increase in the number of pharmaceutical companies outsourcing their work to avoid different hassles, increasing research and development expenditure, and an increasing demand for outsourcing clinical trials services and analytical testing. Besides, the invitro screening services addresses the most complex challenges in early-stage discovery to help inform development strategies, improve safety margins and reduce attrition rates. The drug discovery screening is the process through which potential drugs are detected and optimized before selection of a candidate drug to progress to clinical trials.

GlycoMar offers a suite of cost effective primary screens, using cells from healthy human donor volunteers and cell lines: